Trial intelligence / Profile preview

Comparison of Cetrorelix, MPA, and Dydrogesterone in IVF

NCT05767086Completed

Sponsor
Bezmialem Vakif University
Start
Mar 2023
Primary completion
Sep 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of medroxyprogesterone acetate and dydrogesterone in infertility (3 arms), sponsored by Bezmialem Vakif University. Primary endpoint: Rate of clinical pregnancy. Started Mar 2023; status: completed.

02

Drugs

medroxyprogesterone acetatedydrogesterone
03

Conditions

infertility

Beyond the preview

Go deeper on NCT05767086.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05767086.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call